Intrexon buys SC's Immunologix; Intellikine earns $4M milestone from Infinity Pharma;

 @FierceBiotech: Slideshow: 10 mobile apps in Life Sciences. Report | Follow @FierceBiotech

 @JohnCFierce: Thanks to Bayer, Novo Nordisk, Glaxo, Spinifex and Imperial college for participating on academic/biotech panel at BioEurope. | Follow @JohnCFierce

 @RyanMFierce: Obama steps up action on drug shortages with FDA mandate. News | Follow @RyanMFierce

 @MaureenFierce: Happy Halloween! Check out our 2011 Biotech Graveyard report. Report | Follow @MaureenFierce

> Orlando, FL-based Nephron Pharmaceuticals, a maker of generic respiratory drugs, has unveiled plans for a $313 million plant close to Cayce, SC. "This is a big win for our state," South Carolina Gov. Nikki Haley said, as quoted by the Associated Press. Report

> In more South Carolina life sciences news, Virginia-based synthetic biology upstart Intrexon has bought Charleston, SC, biotech firm Immunologix for an undisclosed sum. Item

> Drug developer Intellikine is owed a $4 million payment from collaborator Infinity Pharmaceuticals for starting two Phase I trials for IPI-145, a PI3K inhibitor under investigation as a treatment for blood cancers. Release

> Pulmatrix, a venture-backed biotech start-up in Lexington, MA, has revealed upbeat data from in vitro data on the use of its inhaled delivery platform to transport the active ingredient in Advair. Item

Pharma News

 @FiercePharma:  Momenta wins injunction against rival Lovenox copy, thwarting Amphastar/Watson. News | Follow @FiercePharma

> Laid-off Pfizer rep won't return $411K in overpaid severance. Article

> Reuters: Emerging markets are no panacea. Report

> Basel protestors march against Novartis cuts. Item

> Obama to order new FDA action on drug shortages. Report

Biotech IT News

> Suspected anti-Parkinson's gene spotted in 23andMe database. Story

> PLoS tackles bioinformatics for beginners. News

> J&J links up with Foundation Medicine for cancer genomic test. ncer-genomic-test/2011-10-28">Article

> McGill U. teams with eVision to speed clinical trial starts. News

> TrialReach rounds up $1.2M for online trial recruitment. Item

Medical Device News

> Stratatech gets $4.6M for skin substitute trial. News

> BD debuts AutoShield Duo. Story

> FDA OKs Gen-Probe HPV test. Report

> Occlutech scores another win against St Jude-AGA Medical. Item

> FDA OKs Medtronic study for Type 1 diabetes management. Article

> FDA panel gives AtriCure good news on Synergy system. Story

And Finally... LabX Media Group has snapped up The Scientist print magazine and digital publication from Sciencenow. Release